Search for: "Andrx Pharmaceutical, Inc."
Results 1 - 11 of 11
Sorted by Relevance | Sort by Date
RSS Subscribe:  20 results  |  100 results
23 Apr, 2007 8:43 am by Barry Barnett
The Federal Circuit today upheld a post-trial judgment that Andrx literally infringed several claims of a patent covering the blockbuster drug Prilosec, which inhibits production of gastric acid. The court also affirmed the district court's ... the tests for "inherent anticpation" by prior art and obviousness. In re Omeprazole Patent Litig. (Astra Aktiebolag v. Andrx Pharmaceuticals, Inc.) , Nos. 04-1562, 04-1563 & 1589 (Fed. Cir. Apr. 23, 2007). Barry Barnett Get our patently free feed.
Blawgletter - http://blawgletter.typepad.com/bbarnett/
16 Oct, 2006 7:58 pm by Aaron Barkoff
... Andrx's attempt to market generic Cardizem. Novartis sued Par Pharmaceuticals, the third and most recent company to file an ANDA for generic Lotrel. Schering-Plough sued over ... ), had sales of $846 million last year. Alza had also sued Andrx over its own ANDA, but the Stipulated Order dismissing the suit did not mention ... case against Andrx. Source: Impax press release. Solvay Pharmaceuticals settled patent litigation with generic drug makers Par Pharmaceutical Cos. and Watson Pharmaceuticals Inc. ...
Orange Book Blog - http://www.orangebookblog.com/
12 Nov, 2006 8:20 pm by tennisper
Shire Laboratories, Inc. filed suit against Andrx Pharmaceuticals LLC and Andrx Corp., for patent infringement. The suit, filed in the U.S. District Court for the District of New Jersey and the Southern District of Florida, alleges Andrx infringed upon two patents. The suit was filed in response to an Andrx new drug application for several generic versions [...]
Pierce Law IP News Blog - http://ipnewsblog.com
14 May, 2008 7:57 am by All Language Alliance, Inc.
... issue, which holds that if the communication touches base with the U.S., U.S. laws will be applied. On the other hand, if the communications relates to matters only involving the foreign country, that foreign country's laws will be applied. Aktiebolag v. Andrx Pharmaceuticals, Inc., 208 F.R.D. 92, 97-98 (S.D.N.Y. 2002); Golden Trade, S.r.L. v. Lee Apparel Co., 143 F.R.D. 514, 520 (S.D.N.Y. 1992). This ...
Translation For Lawyers - http://www.translationforlawyers.com/
4 Dec, 2007 9:28 pm by Donald Zuhn
By Sherri Oslick -- Biovail Laboratories International SRL, a subsidiary of Biovail Corporation, and Watson Pharmaceuticals, Inc., have announced that they have reached a settlement agreement in Biovail's lawsuit against Andrx Pharmaceuticals, Inc., a subsidiary of Watson. The lawsuit was filed following a paragraph IV certification as part of Andrx's...
Patent Docs - http://patentdocs.typepad.com/patent_docs/
8 Dec, 2007 11:00 am
... ) - AstraZeneca receives 6 mth pediatric exclusivity: (Competitive Info), Cardizem (Diltiazem) - Biovail and Andrx Pharmaceuticals settle patent litigation: (IPLaw360), (Generic Pharmaceuticals & IP), (BIO Smartbrief), (Patent Docs), Celebrex (Celecoxib) - Pfizer ... : (IPLaw360), (Washington State Patent Law Blog), Microsoft - Anascape Ltd., Microsoft Corp. and Nintendo Inc - Markman claim construction handed down: (IPLaw360), Motion Picture Association of America (MPAA) - content filtering is ...
IP Thinktank - http://duncanbucknell.com/blog
2 Sep 11:22 pm by Beck/Herrmann
... regarding defendant's alleged failure to report and to investigate adverse incidents to the FDA"); Andrx Pharmaceuticals v. Biovail Corp., 175 F. Supp.2d 1362, 1369-70 ... " claims that "are premised on false representations to the FDA. . .are clearly preempted"); Rosner v. Mira, Inc., 2004 WL 5519541 (N.Y. Sup. Oct. 18, 2004) (fraud on ... dead letters, unless the Eighth Circuit does something unusual. Compare In re Medtronic, Inc. Sprint Fidelis Leads Products Liability Litigation, 592 F. Supp.2d 1147 ...
Drug and Device Law - http://druganddevicelaw.blogspot.com
24 Apr, 2007 4:18 pm by Stephen Albainy-Jenei
... Prilosec, Astra's gastric acid inhibiting drug, for infringement of a patent directed to a process for making an omeprazole formulation. Andrx filed counterclaims of non-infringement, invalidity and unenforceability for inequitable conduct during prosecution of the ' ... , and an enteric coating layer. Specifically, the '281 patent recites: 1. A process for preparing an oral pharmaceutical formulation comprising the steps of: forming a core material comprising a proton pump inhibitor and at least one ...
Tags: Litigation, IP
Patent Baristas - http://www.patentbaristas.com/
2 Aug, 2008 12:54 am
... finance), Ritalin (Methylphenidate) - US: Celgene wins bid to have Buchanan Ingersoll disqualified from representing KV Pharmaceutical in longstanding patent dispute over Ritalin: (Law360), Sensipar (Cincalcet hydrochloride) - US: Barr confirms challenge of ... US: CAFC rejects antitrust class actions claiming Biovail violated antitrust law by using patent litigation to keep Andrx from making generic Tiazac: (Law360), Viread (Tenofovir) - UK: British court allows Gilead's appeal against Comptroller' ...
IP Thinktank - http://duncanbucknell.com/blog
25 Jul, 2007 3:15 pm by Stephen Albainy-Jenei
... Court of Appeals for the Federal Circuit, No. 06-1254. AstraZeneca sued after Andrx filed an Abbreviated New Drug Applications (ANDA) seeking FDA approval to market ... and filed a patent application on delayed and extended release dosage forms of pharmaceutical compositions, including metoprolol succinate As these things go, Astra of course noticed ... Geneva Pharms., Inc. v. GlaxoSmithKline PLC, 349 F.3d 1373, 1382-83 (Fed. Cir. 2003) (holding that later patent claiming pharmaceutical composition ...
Tags: Current, Affairs
Patent Baristas - http://www.patentbaristas.com/
24 Jul, 2006 2:37 pm
Case: Abbott Laboratories v. Andrx and Teva Pharmaceuticals USA, Inc., No. 05-1433 (Fed. Cir. 6/22/06) The One Sentence Summary: Over a dissent, the Federal Circuit reversed the granting of a preliminary injunction to Abbott, after Teva raised "substantial questions" regarding the obviousness of Abbott's patented invention of extended release clarithromycin. What They Were Fighting About: Abbott developed and patented an extended release formulation of ...
IP Law Observer - http://www.iplawobserver.com
         
Add to your RSS Reader Add to your Google Add to your My Yahoo Add to your My MSN Add to your My AOL Add to your Feedster Add to your Newsgator Add to your Bloglines Add to your NewsBurst Add to your Rojo Add to your Pluck